Nasdaq · Common stock
Iambic Therapeutics (IAM)
$14.41 +$0.15 (+1.05%)
- Day’s range
- $14.00–$15.25
- Volume
- 148,953
IAM price history
IAM closed at $14.41 on Oct. 26, 2026. Over the past year, its daily close ranged from $14.26 on Oct. 23, 2026 to $23.81 on Oct. 16, 2026.
Data table: IAM daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $14.41 |
| Oct. 23, 2026 | $14.26 |
| Oct. 22, 2026 | $14.67 |
| Oct. 21, 2026 | $15.80 |
| Oct. 20, 2026 | $16.01 |
| Oct. 19, 2026 | $16.34 |
| Oct. 16, 2026 | $23.81 |
| Oct. 15, 2026 | $18.91 |
Key figures
- Average daily volume
- 1.3MPast 3 months
- Market value
- $683.0M
- Dividend yield
- —
What Wall Street says about IAM
No Wall Street firm has published a rating or price-target change on IAM in the past 90 days.
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Iambic Therapeutics, Inc. Common Stock
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
- Listed
- Oct. 15, 2026
In WallStreetDigest editions
No WallStreetDigest article about IAM is on the site yet.